"NOW OPEN @RutgersCancer: “A Phase I/II Study of OBI-3424 in Subjects with Advanced Solid Tumors.” #ClinicalTrial @HH_Oncodr @RWJBarnabas https://t.co/jOC77gtjeV"

OBI-3424 - OBI Pharma

Mar 26, 2022